Link by http://www.biomedcentral.com/1472-6963/12/39

Link by http://www.plosone.org/article/infodoi10.1371journal.pone.0029775

Link by http://www.health-policy-systems.com/content/10/1/6/abstract

Link by http://www.cgdev.org/section/topics/global_health/working_groups/priority_setting_institutions

Efficiency or equity: value judgments in coverage decisions in Thailand. Sripen Tantivess, Román Pérez Velasco, Jomkwan Yothasamut, Adun Mohara, Hatai Limprayoonyong, Yot Teerawattananon, (2012) “Efficiency or equity: value judgments in coverage decisions in Thailand”, Journal of Health Organizat

Lessons drawn from research utilization in the maternal iodine supplementation policy development in Thailand. Utsana Tonmukayakul, Román Pérez VelascoEmail author, Sripen Tantivess and Yot Teerawattananon Abstract In this paper, the authors share their experience on evidence utilization in

For full text, click here http://www.translational-medicine.com/content/pdf/1479-5876-11-1.pdf

Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand. Waranya Rattanavipapong1, Tanunya Koopitakkajorn1, Naiyana Praditsitthikorn1,2,*, Surakameth Mahasirimongkol3 andYot Teerawattananon1 Summary Purpose There is strong evidence o

Abstract Objectives In Thailand, axillary lymph node dissection (ALND) is the dominant form of treatment for breast cancer, even though the treatment often leaves patients with some degree of arm morbidity. Sentinel lymph node biopsy (SNB) is widely accepted globally as a preferable alternative pr

Background: In Thailand, there has been no economic evaluation study of adjuvant chemotherapy for stage III colon cancer patients after resection. Objective: This study aims to evaluate the cost-utility of all chemotherapy regimens currently used in Thailand compared with the adjuvant 5-fluorouracil